Roberto A. Mignone - 19 Sep 2026 Form 4 Insider Report for TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA)

Reporting relationship: Director
Issuer ticker: TEVA
Reported as of: 19 Sep 2026
Net transaction value: -$14,356,802
SEC form: 4
Accepted by SEC: 22 Sep 2026, 16:21:45 UTC
Prior SEC filing: 24 Aug 2026
Next SEC filing: 22 Sep 2026
Source filing: View source filing
Reporting owner signature: /s/ Dov Bergwerk as attorney-in-fact for Roberto Mignone

Key filing fact

Roberto A. Mignone filed Form 4 for TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA) on 22 Sep 2026.

Key facts

This page summarizes Roberto A. Mignone's Form 4 filing for TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA).
1 reported transaction and 0 derivative rows are listed below.
Accepted by SEC: 22 Sep 2026, 16:21.

Change

Previous filing in this sequence was filed on 24 Aug 2026.
Current net transaction value: -$14,356,802.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001258394 Primary reporting owner

MIGNONE ROBERTO

Relationship: Director
Address: C/O TEVA PHARMACEUTICAL INDUSTRIES LTD., 124 DVORA HANEVI'A ST.,, TEL AVIV, ISRAEL
Signature: /s/ Dov Bergwerk as attorney-in-fact for Roberto Mignone
Signature date: 22 Sep 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

TEVA transaction

Ordinary Shares

Sale

Transaction value: $14,356,802
Shares: -367,600
Change %: -100%
Price: $39.06
Shares after: 0
Date: 18 Sep 2026
Ownership: [see footnote]
Footnotes: F1, F2

TEVA holding

Ordinary Shares

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 119,807
Date: 19 Sep 2026
Ownership: Direct

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 2 footnotes

Footnote F1

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $38.68 to $39.38, inclusive. The reporting person undertakes to provide, upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares sold at each separate price.

Footnote F2

The 367,600 Ordinary Shares disclosed in Table I of this Form 4 were held of record by Swiftcurrent Master Fund Ltd. (the "Fund"). Bridger Management, LLC is the investment adviser to the Fund and Mr. Mignone is the manager of Bridger Management, LLC. By reason of the provisions of Rule 16a-1(a)(1) under the Securities Exchange Act of 1934, as amended, Mr. Mignone was deemed to beneficially own the Ordinary Shares held of record by the Fund. Mr. Mignone disclaimed beneficial ownership of the Ordinary Shares held of record by the Fund except to the extent of his indirect pecuniary interest therein and this report shall not be deemed an admission that Mr. Mignone was the beneficial owner of the Ordinary Shares held of record by the Fund for purposes of Section 16, or for any other purpose.